Mirodenafil NEW
| Price | $44 | $72 | $136 |
| Package | 5mg | 10mg | 25mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-19 |
Product Details
| Product Name: Mirodenafil | CAS No.: 862189-95-5 |
| Purity: 99.89% | Supply Ability: 10g |
| Release date: 2024/11/19 |
Product Introduction
Bioactivity
| Name | Mirodenafil |
| Description | Mirodenafil is a PDE-5 inhibitor developed for the treatment of erectile dysfunction. |
| In vitro | The pharmacoki-netics of mirodenafil were not significantly altered by this concurrent administration. Mirodenafil (50 or 100 mg), obviously improved erectile function and was well tolerated in a representative population of Korean men with broad-spectrum ED of various etiologies and severities [1]. Mirodenafil administered with alcohol had a tolerability profile comparable to that of mirodenafil alone [2]. The concurrent administration of mirodenafil with alcohol was not associated with clinically significant hemodynamic changes in these healthy male volunteers in Korea. The coadministration of ketoconazole and rifampicin resulted in significant changes in systemic exposure to mirodenafil, in these healthy Korean male volunteers [3]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 27.5 mg/mL (51.72 mM) |
| Keywords | Beta catenin | SK-3530 | Glucocorticoid Receptor | Wnt | Apoptosis | β-catenin | inhibit | systemic sclerosis | NIH3T3 | erectile dysfunction | Alzheimer’s disease | HT-22 cells | SH-SY5Y | MRC-5 cells | fibrosis | Inhibitor | Mirodenafil | Phosphodiesterase (PDE) | SK 3530 |
| Inhibitors Related | Theophylline monohydrate | Roflumilast | Theobromine | Apremilast | Isoprenaline hydrochloride | Indomethacin | Icariin | Theophylline | Vardenafil hydrochloride | Doxofylline |
| Related Compound Libraries | Bioactive Compound Library | ReFRAME Related Library | Inhibitor Library | NO PAINS Compound Library | Anti-Cardiovascular Disease Compound Library | Metabolism Compound Library | Bioactive Compounds Library Max | Anti-Metabolism Disease Compound Library | Human Metabolite Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1.00/1kg |
VIP2Y
|
Jinan Million Pharmaceutical Co., Ltd
|
2025-01-01 | |
| $10.50/1KG |
VIP4Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-21 | |
| $11.00/1kg |
VIP1Y
|
Hebei Ganmiao New material Technology Co., LTD
|
2024-06-17 | |
| $25.00/1kg |
Sigma Audley
|
2024-02-22 | ||
| $0.00/1kg |
VIP3Y
|
Wuhan Senwayer Century Chemical Co.,Ltd
|
2023-05-12 | |
| $1.00/1g |
VIP2Y
|
Wuhan Cell Pharmaceutical Co., Ltd
|
2023-04-25 | |
| $59.00/1KG |
Qiuxian Baitai New Material Co., LTD
|
2021-11-04 | ||
| $3000.00/1KG |
Hubei Langyou International Trading Co., Ltd
|
2021-09-01 | ||
| $1.00/1g |
Wuhan Boyuan Import & Export Co., LTD
|
2021-08-12 | ||
| $10.00/1KG |
Hubei Aumei New Material Co., Ltd.
|
2021-08-04 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY